Monday, 26 Oct 2026

Empowering Chinese Pharma’s Global Expansion

Contact US
Insight,  China's Pharmaceutical Industry
  • Home
  • About US
  • Policy Hub
  • Categories
    • Drug
    • Company
    • Deals
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Legal / IP
    • Digital
  • Privacy Policy
  • Contact US
My News
  • Cancer
  • Clinical trial approval / initiation
  • Product approvals
  • Clinical trial results
  • Finance
  • ADC / XDC
  • Finanical Reports
  • Biotech
  • Market approval filings
  • PD-1/L1
Insight,  China's Pharmaceutical IndustryInsight,  China's Pharmaceutical Industry
  • Read History
Search
  • Pages
    • Home
    • Blog Index
    • POLICY HUB
    • Contact Us
  • Personalized
    • Read History
  • Categories
    • Company
    • Drug
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Digital
    • Legal / IP
    • Deals
Have an existing account? Sign In
Follow US
Hengrui Pharmaceuticals Receives NMPA Clearance for HRS-5635 in Chronic HBV
CompanyDrug

Hengrui Pharmaceuticals Receives NMPA Clearance for HRS-5635 in Chronic HBV

April 30, 2025
Fosun Pharma's Henlius Strikes Deal with Sandoz for Global Rights to HLX13 Biosimilar
CompanyDeals

Fosun Pharma’s Henlius Strikes Deal with Sandoz for Global Rights to HLX13 Biosimilar

April 30, 2025
BeiGene Wins USPTO Ruling Invalidating Pharmacyclics' Patent Claims
Legal / IP

BeiGene Wins USPTO Ruling Invalidating Pharmacyclics’ Patent Claims

April 30, 2025
AstraZeneca's Q1 2025 Results: 10% Revenue Growth, Oncology Segment Shines
Company

AstraZeneca’s Q1 2025 Results: 10% Revenue Growth, Oncology Segment Shines

April 30, 2025
Pfizer's Q1 2025 Results: Revenues Down 6% YOY Amid Paxlovid, IRA Impact
Company

Pfizer’s Q1 2025 Results: Revenues Down 6% YOY Amid Paxlovid, IRA Impact

April 30, 2025
United Imaging Healthcare Reports 9.73% Revenue Decline in 2024 Financials
Company

United Imaging Healthcare Reports 9.73% Revenue Decline in 2024 Financials

April 29, 2025
Innovent Biologics Expands Clinical Partnership with ImmVirX to Include Hepatocellular Carcinoma
CompanyDeals

Innovent Biologics Expands Clinical Partnership with ImmVirX to Include Hepatocellular Carcinoma

April 29, 2025
Boehringer Ingelheim's Zongertinib Shows Promising Results in HER2-Mutant NSCLC Trial
CompanyDrug

Boehringer Ingelheim’s Zongertinib Shows Promising Results in HER2-Mutant NSCLC Trial

April 29, 2025
Kangpu Biopharmaceuticals Receives NMPA Approval for KPG-818 Phase IIb Study in SLE
CompanyDrug

Kangpu Biopharmaceuticals Receives NMPA Approval for KPG-818 Phase IIb Study in SLE

April 29, 2025
WuXi AppTec Reports 21.0% YOY Revenue Growth in Q1 2025
Company

WuXi AppTec Reports 21.0% YOY Revenue Growth in Q1 2025

April 29, 2025
Frontera Therapeutics' Gene Therapy FT-017 Gains Clinical Trial Approvals for HCM
CompanyDrug

Frontera Therapeutics’ Gene Therapy FT-017 Gains Clinical Trial Approvals for HCM

April 29, 2025
Johnson & Johnson's TAR-200 Shows Promising Results in Phase IIb SunRISe-1 Study for Bladder Cancer
CompanyDrug

Johnson & Johnson’s TAR-200 Shows Promising Results in Phase IIb SunRISe-1 Study for Bladder Cancer

April 29, 2025
1 2 3 4 … 29 30
Insight,  China's Pharmaceutical Industry

Information You Can Trust: Stay instantly connected with breaking stories and live updates. From politics and technology to entertainment and beyond, we provide real-time coverage you can rely on, making us your dependable source for 24/7 news.

Youtube Medium Rss

About Company

  • Contact Us
  • Advertise with US
  • Complaint
  • Our Team
  • Our Values
  • Privacy Policy
Subscribe Now for Real-time Updates on the Latest Stories!

© 2026 Fineline Information & Technology. Independent intelligence on China’s pharmaceutical industry.  All Rights Reserved.

Fineline Information & Technology
Welcome to Fineline Cube!
Username or Email Address
Password

Lost your password?

Not a member? Sign Up